House of Lords Business
Show full summary

Lord Hunt of Kings Heath to ask Her Majesty's Government what action can be taken by thyroid patents who in raising concerns about the Birmingham and Solihull Clinical Commissioning Group's (CCG) refusal to allow the prescription of liothyronine, were told by that CCG to raise the issue with NHS England only to be told by NHS England to raise the matter with that CCG.  HL454

Question HL454: tabled on 28 October 2019 and due for answer by 11 November 2019

This type of business sits within the Questions & Statements category.

This question has been answered by the relevant Government Department.

Question text

Lord Hunt of Kings Heath to ask Her Majesty's Government what action can be taken by thyroid patents who in raising concerns about the Birmingham and Solihull Clinical Commissioning Group's (CCG) refusal to allow the prescription of liothyronine, were told by that CCG to raise the issue with NHS England only to be told by NHS England to raise the matter with that CCG.  HL454
Legend for business item text
† Item that is new or altered.
* Item is an oral question.
Numbers starting HL are unique identifiers for written questions, Bills or papers.

Member's Registered Interests

There are no interests to show.

Main Member

Lord Hunt of Kings Heath
Labour
Life peer